טוען...

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

OBJECTIVE: Compared with tenofovir disoproxil fumarate (TDF), tenofovir alafenamide (TAF) has been associated with improvement in markers of renal dysfunction in individual randomized trials; however, the comparative incidence of clinically significant renal events remains unclear. DESIGN: We used a...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:AIDS
Main Authors: Gupta, Samir K., Post, Frank A., Arribas, José R., Eron, Joseph J., Wohl, David A., Clarke, Amanda E., Sax, Paul E., Stellbrink, Hans-Jürgen, Esser, Stefan, Pozniak, Anton L., Podzamczer, Daniel, Waters, Laura, Orkin, Chloe, Rockstroh, Jürgen K., Mudrikova, Tatiana, Negredo, Eugenia, Elion, Richard A., Guo, Susan, Zhong, Lijie, Carter, Christoph, Martin, Hal, Brainard, Diana, SenGupta, Devi, Das, Moupali
פורמט: Artigo
שפה:Inglês
יצא לאור: Lippincott Williams & Wilkins 2019
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6635043/
https://ncbi.nlm.nih.gov/pubmed/30932951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000002223
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!